Exhibit 99.2 Arcadia Biosciences, Inc. Consolidated Balance Sheets (Unaudited) (In thousands, except share data) As of December 31, 2023 2022 Assets Current assets: Cash and cash equivalents $ 6,518 $ 20,644 Short-term investments 5,124 — Accounts receivable and other receivables, net of allowance for doubtful accounts of $0 and $3 as of December 31, 2023 and 2022, respectively 514 1,221 Inventories, net — current 1,958 2,321 Assets held for sale 51 87 Prepaid expenses and other current assets 807 795 Curre ...